Opinion
Video
Treatment Options for Patients With Metastatic Melanoma With a BRAF Mutation
Author(s):
For patients with BRAF-mutant metastatic melanoma, doctors assess symptoms and disease status to determine if they should start treatment with combination immunotherapy, or 8-12 weeks of BRAF/MEK targeted therapy before switching to immunotherapy, which offers the possibility of durable responses or cure.
Related Videos
Related Content
